EUIPO The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.
Protect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark TREATMENTMAP - WHOLE EXOME was filed as Word mark on 10/08/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/08/2015.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 013338181 |
| Application date | October 8, 2014 |
| Publication date | June 1, 2015 |
| Entry date | September 8, 2015 |
| Expiration date | October 8, 2024 |
Trademark owner
Kurfürsten-Anlage 21
69115 Heidelberg
DE
69115 Heidelberg
DE
Trademark representatives
Prinzregentenstr. 68
81675 München
DE
goods and services
10
Medical equipment for genome analysis in cancer diagnostics, for the diagnosis of genomic changes and tests at the molecular level, in particular laboratory equipment for next generation sequencing (NGS), in particular laboratory equipment for next generation sequencing (NGS) in the context of clinical and medical applications, and instruments for assisting automated decisions for diagnostic and therapeutic applications; Surgical, medical, dental and veterinary apparatus and instruments; Testing apparatus for medical applications; Surgical implants; Physical activity apparatus for medical purposes
42
Services for providing data for scientific, analytical and clinical purposes, in particular collation and systematic review of patient-specific molecular, genomic and/or clinical data, in particular in relation to changes at the genome level, in particular in relation to changes at the genome level in the case of cancer diseases; Providing medical information by collecting and analysing genetic information and information relating to the treatment of cancer diseases and other diseases and health disorders; scientific clinical studies; Compilation of data for basic research and for analytical purposes, in particular compilation of mathematical and statistical data, clinical data, data relating to genome analysis of patients and data from clinical studies relating to the clinical reaction behaviour of a patient to certain medication and treatment methods; The bringing together of data for the purposes of research and analysis in the field of medical science and diagnostics, in particular the bringing together of patient-specific molecular and genomic data, in particular genomic data relating to cancer diseases; Services in the field of science, technology and research, in particular for medical purposes in the field of medical diagnostics and treatment optimisation; Providing of medical and scientific information and scientific consultancy in the field of pharmaceutical side effects, genomic analysis, cancer medicine and translational medicine; Providing services in the field of next generation sequencing (NGS), including analysis and interpretation of the data obtained, in particular data obtained from cancer patients, in particular analysis and interpretation of changes in the genome which contribute to the particular cancer of the patient; Providing search engines for the internet comprising medical, pharmaceutical, biological and/or genetic information for medical and diagnostic purposes; Providing search engines for the internet with an online search function comprising medical, pharmaceutical, biological, clinical and/or genomic information for scientific, analytical and clinical purposes; Providing search engines with an online search function in the field of cancer medicine, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis; Design and development of computer software in the field of biology, medicine and bioinformatics; Design and development of computer software for the integration of patient-specific data, molecular test results, clinical studies and scientific research results; Providing non-downloadable computer software for use by specialised medical personnel for medical diagnostics and treatment, in particular in the field of cancer diagnostics and therapy; Design and development of databases comprising biomarker data; Providing of databases with an online search function for medical and diagnostic research and clinical application, and for analysis and optimisation of treatment protocols; Software as a service (SaaS) and providing computer software for optimising the treatment of patients by extracting and correlating genomic data, the creation of active ingredient protocols and clinical profiles, integration and statistical analysis of data for medical purposes; Providing of non-downloadable computer software for obtaining and for the correlation of genomic data, active ingredient protocols, clinical profiles, and for the integration and statistical analysis of data for medical diagnostics and treatment purposes; Medical and scientific research and scientific consultancy, in particular design and conducting of studies relating to medicine safety and medicine compatibility in the field of cancer therapy and in the field of other disorders
44
Providing online databases containing medical, pharmaceutical and genomic information; Consultancy relating to medicines and genetics with regard to medical treatment methods for individual patients, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy; Medical consultancy relating to the treatment and diagnosis of individuals in the field of clinical pharmacology and the analysis of dose-effect curves for treatment purposes; Providing pharmacological information, in particular relating to medicine safety and active ingredient compatibility in cancer therapy and the treatment of individuals; Medical consultancy in the field of patient treatment and treatment protocols; Consultancy in the field of medicine and genetics, in particular conducting of experiments relating to medicine safety and dosing, and experiments relating to medicine compatibility in the field of cancer therapy, for others; Medical tests at the molecular level and at the genome level for diagnostics and treatment purposes, in particular in cancer diagnostics and cancer therapy; Diagnostic services for cancer patients and patients with other diseases and health disorders; Conducting of molecular tests and cancer tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods; In particular the analysis of genomic changes through next generation sequencing of patient DNA; Collation and analysis of genetic information in connection with cancer diseases and other treatment; Medical data and information processing, storage and communication to doctors and specialised medical personnel; Providing an information platform containing information relating to cancer profiles of individual patients and changes at the genome level that are seen with cancer, in order to enable doctors and specialised medical personnel to optimise treatment methods in clinical practice
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| March 12, 2024 | Extension, Notification of expiry of trade mark | ||
| January 16, 2019 | Change Representative, Published | ||
| January 16, 2019 | Change Representative, Published | ||
| December 1, 2015 | Transfer / Change of address, Published | ||
| June 10, 2015 | Transfer / Change of address, Published |
ID: 11013338181